Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fulcrum Therapeutics (FULC) Receivables - Net (2020 - 2022)

Historic Receivables - Net for Fulcrum Therapeutics (FULC) over the last 3 years, with Q3 2022 value amounting to $13000.0.

  • Fulcrum Therapeutics' Receivables - Net changed N/A to $13000.0 in Q3 2022 from the same period last year, while for Sep 2022 it was $13000.0, marking a year-over-year change of. This contributed to the annual value of $2.5 million for FY2021, which is 2500.0% up from last year.
  • Latest data reveals that Fulcrum Therapeutics reported Receivables - Net of $13000.0 as of Q3 2022.
  • Fulcrum Therapeutics' 5-year Receivables - Net high stood at $2.5 million for Q4 2021, and its period low was $13000.0 during Q3 2022.
  • In the last 3 years, Fulcrum Therapeutics' Receivables - Net had a median value of $1.2 million in 2020 and averaged $1.2 million.
  • Examining YoY changes over the last 5 years, Fulcrum Therapeutics' Receivables - Net showed a top increase of 2500.0% in 2021 and a maximum decrease of 2500.0% in 2021.
  • Over the past 3 years, Fulcrum Therapeutics' Receivables - Net (Quarter) stood at $2.0 million in 2020, then increased by 25.0% to $2.5 million in 2021, then crashed by 99.48% to $13000.0 in 2022.
  • Its Receivables - Net was $13000.0 in Q3 2022, compared to $357000.0 in Q2 2022 and $2.5 million in Q4 2021.